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Abstract The role of residues predicted to be involved in the
binding of iron by the yeast ferroxidase Fet3 has been studied by
site-directed mutagenesis. The effect of Fet3 mutations E185A,
E185Q, Y354F, D409V and H489D has been investigated in vivo
by kinetic analyses of high affinity iron uptake. Our results
indicate that Glu-185 is critical for the binding of iron, since
substitution of this residue with Ala or Gln strongly affects both
growth and the kinetic parameters of high affinity iron uptake,
greatly increasing Km. Mutations Y354F and D409V result in
less severe alteration of high affinity iron uptake, while mutant
H489D is unable to grow under conditions of iron
limitation. ß 2001 Published by Elsevier Science B.V. on be-
half of the Federation of European Biochemical Societies.
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1. Introduction
Iron is essential for living cells, however it can become
extremely toxic if its intracellular levels are too high. Thus,
cells have evolved sophisticated systems to control iron up-
take. In the yeast Saccharomyces cerevisiae a low a⁄nity and
a high a⁄nity iron uptake system have been recently discov-
ered [1]. The ferroxidase Fet3 is a key component of the yeast
high a⁄nity iron uptake system together with the iron perme-
ase Ftr1 [1,2]. It has been proposed that extracellular Fe(III)
is reduced by metalloreductases belonging to the Fre family of
proteins, subsequently Fet3 oxidizes Fe(II) to Fe(III), which is
then transported into the cell through Ftr1. Fet3 belongs to
the family of the blue multicopper oxidases, which are able to
couple the one-electron oxidation of substrates to full reduc-
tion of molecular oxygen to water, avoiding release of reactive
partially reduced oxygen species. This ability is provided by
the presence of type 1 blue copper, which is the primary elec-
tron acceptor from the reducing substrate, and of a trinuclear
copper cluster, formed by type 2 and binuclear type 3 copper,
which constitutes the oxygen binding and reduction site [3].
Thus, electrons £ow from reduced type 1 copper to the trinu-
clear copper cluster through a branched His^Cys^His path-
way, where the type 1 copper Cys ligand is £anked by two of
the trinuclear cluster His ligands. In the multicopper oxidases,
substrate binding is predicted to take place close to type 1
copper; in particular, in Fet3 an iron binding site has been
proposed to be formed by residues Glu-185, Tyr-354, Asp-409
and possibly the type 1 copper ligand His-489, on the basis of
homology modeling [4]. We have clearly established the role
of Glu-185 and Tyr-354 by site-directed mutagenesis and in
vitro assay of the ferroxidase activity of recombinant Fet3
E185A and Y354F [5].
To further investigate the functional properties of Fet3, we
have produced di¡erent Fet3 mutants in which each of the
residues proposed to be required for binding of iron has been
substituted by site-directed mutagenesis. The mutant proteins
have been expressed in a S. cerevisiae strain lacking endoge-
nous Fet3 and the functional relevance of the mutations in-
troduced has been assayed in vivo by complementation of the
growth defect of the vfet3 strain under conditions of iron
limitation and by estimation of the kinetic parameters of
high a⁄nity iron transport.
2. Materials and methods
2.1. Yeast strains and culture media
S. cerevisiae strains DY150 (MATa, ura3-52, leu2-3, 112, trp1-1,
his3-11, ade2-1, can1-100(oc)) and DEY1397-6A (MATK,
fet3: :HIS3, ade2, can1, his3, leu2, trp1, ura3) were a generous gift
of Professor J. Kaplan. Yeast cells were grown at 30‡C in minimal
medium (0.67% yeast nitrogen base without amino acids, with the
necessary auxotrophic supplements) with 2% glucose (MD) or 2%
galactose (MGal). The medium was bu¡ered to pH 6 with 100 mM
potassium phosphate bu¡er and made iron-limited by addition of the
iron chelator bathophenanthrolinedisulfonate (BPS) 80 WM. The
amount of iron in bu¡ered MGal was estimated to be 1^1.2 WM by
colorimetric determination with BPS (O535 22 400 M31 cm31) [6].
2.2. Site-directed mutagenesis of Fet3
Site-directed mutagenesis was performed by the polymerase chain
reaction (PCR) megaprimer method [7]. Fet3 mutants E185A and
Y354F have already been described [5]. Mutants E185Q, D409V
and H489D were produced with the following mutagenic primers:
E185Qrev, 5P-tgggatgggctgagcacc-3P ; D409Vfwd, 5P-aaccaggtcacagg-
tacc-3P ; H489Dfwd, 5P-gaatgggatttgttgcaagg-3P. These primers were
used in the ¢rst round of PCR with the external primers K 5P-ggaatt-
catgactaaggctttgct-3P or g 5P-ggaattcttagaagaaccgtttggc-3P (K-E185Q,
D409V-g, H489D-g) to produce the megaprimers, with pBSFet3 wild
type as template. The megaprimers were puri¢ed and employed in the
second round of PCR with the same template, K-E185Q with primer
g, D409V-g with primer K and H489D-g with primer K to obtain the
full-length mutated Fet3 which were cloned in pBluescript. The pres-
ence of the desired mutations was veri¢ed by automated DNA se-
quencing at the Biogen-ENEA facility.
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2.3. Fet3 expression and analysis
The multicopy vector pYeDP1/8-2 [8] was employed for expression
of recombinant wild type and mutant Fet3 under control of the in-
ducible Gal10 promoter. Wild type Fet3 and mutants E185A and
Y354F were cloned in pYeDP via the EcoRI cloning site (pYFet3)
and the correct orientation of the insert was veri¢ed by restriction
analysis. Restriction of pBSFet3 E185Q, D409V or H489D with
Eco72I and Eco91I was carried out to obtain a cassette containing
the desired mutation which was then inserted in pYFet3. The yeast
vfet3 strain DEY1397-6A was transformed by electroporation accord-
ing to standard procedures [9] with wild type and each mutant pYFet3
and with the vector alone. Cells were grown in MGal medium without
uracil and total membrane extracts were obtained following lysis of
cells with glass beads, as described [5]. Total protein content was
determined with the microBCA assay (Pierce). Non-denaturing so-
dium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) and staining for Fet3 oxidase activity with o-dianisidine
were performed as described [5]. Immunodetection of Fet3 was per-
formed with a polyclonal rabbit antibody directed against a peptide
spanning Fet3 residues 164^178, obtained from Primm (Milan, Italy).
The antibody was a⁄nity puri¢ed using peptide coupled to CNBr-
Sepharose (Sigma) according to established methods. SDS^PAGE on
a 7.5% gel was performed under denaturing and reducing conditions,
and was followed by transfer onto nitrocellulose. The blot was incu-
bated with a 1:1000 dilution of the a⁄nity puri¢ed antibody over-
night at 4‡C and developed with the BM Chemiluminescence Western
blotting kit (Roche).
2.4. Iron uptake assay
Cells were grown overnight in MGal medium, inoculated in bu¡-
ered MGal for 8^10 h and 80 WM BPS was added for further 15 h.
Cells were harvested at OD600 0.5^1 and iron uptake was performed
with 55FeCl3 (13.6 mCi/mg, NEN Life Sciences), essentially according
to published procedures [10]. 55Fe uptake was measured at 30‡C for
10 min in 50 mM MES pH 6.1, containing 2% galactose in the pres-
ence of 1 mM ascorbate. The assay samples were chilled on ice,
vacuum ¢ltered through Whatman GF/C glass ¢lters and washed
with 10 ml of ice-cold 20 mM citrate pH 5.5, containing 5 mM
EDTA. When used above 0.2 WM, radioactive iron was diluted with
cold iron and speci¢c activity was adjusted accordingly. Background
levels due to non-speci¢c uptake were obtained on parallel samples
kept on ice and were subtracted before calculation of uptake rates.
Cell-associated radioactivity was measured by liquid scintillation
counting with an LKB 1211 Rackbeta counter.
3. Results
3.1. Expression of Fet3 mutants and e¡ect on growth
The four residues which have been proposed to constitute
the iron binding site of Fet3 have been substituted by site-
directed mutagenesis to generate Fet3 E185A, Fet3 E185Q,
Fet3 Y354F, Fet3 D409V and Fet3 H489D. The recombinant
protein has been expressed under galactose-driven induction
in a S. cerevisiae strain lacking endogenous Fet3. Expression
levels were assayed by Western blot (Fig. 1A) and by non-
denaturing SDS^PAGE followed by oxidase activity staining
(Fig. 1B) of membrane extracts from the recombinant strains.
All mutants showed comparable levels of expression and pro-
duced oxidase-active band similar to that of the wild type
protein, with the notable exception of Fet3 H489D. This latter
mutant produced a very faint immunopositive band with al-
tered electrophoretic mobility, and did not have a detectable
enzymatic activity. Expression of all proteins was found to be
dependent on the presence of galactose in the culture medium
(data not shown).
The ability of recombinant Fet3 to complement the growth
defect of the vfet3 strain under conditions of iron limitation
(bu¡ered MGal supplemented with BPS 80 WM) was investi-
gated (Fig. 2). Growth of the parental strain DY150 was
taken as control. It can be clearly seen that while the vfet3
strain transformed with the expression vector alone is unable
Fig. 1. SDS^PAGE analysis of recombinant Fet3. A: Western blot.
Yeast cells were grown in bu¡ered MGal medium to OD600 1.5 and
membrane extracts were obtained as described in Section 2. 30 Wg
total membrane proteins were loaded in each lane following heat
denaturation in the presence of DTT. A polyclonal anti-Fet3 pep-
tide-antibody was used and the blot was developed with a chemilu-
minescent detection system. B: Oxidase activity. 30 Wg total mem-
brane proteins were loaded in each lane and the gel was stained for
oxidase activity with o-dianisidine.
Fig. 2. Representative growth of cells containing native or recombi-
nant Fet3. Cells were grown to OD600 ca. 3 in bu¡ered MGal, inoc-
ulated to OD600 0.1 in bu¡ered MGal supplemented with BPS 80
WM and grown for further 48 h. See Fig. 3 for speci¢c legend.
Fig. 3. High-a⁄nity iron uptake assay of cells containing recombi-
nant wild type or mutant Fet3. Yeast cells were grown in bu¡ered
MGal supplemented with BPS 80 WM to OD600 0.5^1 and iron
transport was assayed as described in Section 2. Data represent the
mean of at least two independent experiments.
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to grow under these conditions, Fet3 wild type, Y354F and
D409V restore growth rates similar to those of DY150. Mu-
tations E185A and E185Q result in a partial restoration of
growth, albeit at slower rate, while Fet3 H489D is unable to
complement the growth defect of the vfet3 strain under these
conditions of iron limitation. Similar results were obtained
when the medium was supplemented with BPS 40 WM (data
not shown).
3.2. Kinetic parameters for high a⁄nity iron uptake
To study the functional e¡ect of mutant Fet3 on high af-
¢nity iron uptake, yeast cells were grown in the presence of
galactose and of the iron chelator BPS 80 WM. The presence
of BPS is required to induce the synthesis of the endogenous
iron permease Ftr1, which is essential to observe high a⁄nity
iron uptake [11]. High a⁄nity iron uptake assays were carried
out in the presence of ascorbate in order to supply iron as
Fe(II). Fig. 3 presents the iron transport rates obtained for
strains expressing wild type or mutant Fet3. The Km for high
a⁄nity iron uptake varied essentially in line with the observed
e¡ect of mutant Fet3 on growth. The estimation of Km values
for iron is reported in Table 1.
4. Discussion
The ferroxidase Fet3 is an essential component of the yeast
high a⁄nity iron transport system. Binding of ferrous iron by
this enzyme is the ¢rst event in the process, followed by ox-
idation of the metal and translocation to the iron permease
Ftr1, which enables iron to cross the plasma membrane and
safely enter the cell. The structural requirements for substrate
binding by Fet3 have recently begun to be elucidated by site-
directed mutagenesis studies based on homology modeling
and in vitro partial characterization of the protein [5]. We
have extended our previous studies in order to gain further
insight on the functional properties of Fet3. To this end, each
of the residues predicted to be involved in binding of iron has
been replaced to generate a protein with impaired a⁄nity for
its substrate. Expression of mutant Fet3 in a vfet3 strain has
allowed us to monitor directly in vivo the properties of the
high a⁄nity iron transport system constituted by the endog-
enous iron permease Ftr1 and the recombinant ferroxidase
Fet3.
Expression levels of recombinant Fet3 wild type, E185A,
E185Q, Y354F and D409V appeared to be comparable, as
judged by Western blot analysis and by the oxidase-active
band detected by non-denaturing SDS^PAGE. The functional
e¡ect of the di¡erent mutations was studied in vivo under
conditions of iron limitation by monitoring cell growth and
high a⁄nity iron uptake rates. Recombinant Fet3 wild type
fully complements the growth defect of the vfet3 strain. On
the other hand, the mutant Fet3 can be divided in two
groups: substitution of Glu-185 either by Ala or Gln has a
severe impact on growth rate, while replacement of Tyr-354 or
Asp-409 apparently restores growth rates similar to those ob-
tained with the wild type protein. In line with this observa-
tion, high a⁄nity iron uptake by the strains expressing the
di¡erent mutant Fet3 exhibits this same trend. While varia-
tions in Vmax can be di⁄cult to interpret, as they can be due
also to slight di¡erences in Fet3 and/or Ftr1 expression levels,
the Km value for iron, which will not depend on enzyme levels
at substrate concentrations much higher than those of the
enzyme, is also the kinetic parameter which is expected to
be a¡ected most by the mutations introduced on Fet3. As a
matter of fact, the results reported in Fig. 3 and Table 1 show
that Km for iron is increased for mutant Fet3 compared to the
wild type protein. Substitution of Glu-185 in Fet3 E185A and
E185Q results in a similar ca. ¢ve-fold increase in Km, while
Fet3 Y354F and D409V exhibit a ca. two-fold increase in Km.
It is interesting to point out that these results compare well
with the Km values obtained in vitro on Fet3 E185A and
Y354F, which showed a ca. 6-fold and 1.5-fold increase,
with respect to Fet3 wild type [5]. Moreover, it is worth noting
that, as previously reported [10,12], the Km value for iron of
the high a⁄nity uptake system is lower than that of puri¢ed
Fet3. This appears to be a general feature as also the high
a⁄nity system of the yeast Pichia pastoris shows a lower Km
compared to puri¢ed Fet3, both Km values being higher than
those for S. cerevisiae [13]. This ¢nding suggests that interac-
tions of Fet3 with other component(s), such as the permease
Ftr1, might modulate the overall a⁄nity of the system for
iron. However, it is clear from the results reported in this
paper that the ferroxidase reaction catalyzed by Fet3 may
be the rate limiting step in the high a⁄nity iron transport
system of S. cerevisiae, at least under physiological conditions,
when the machinery presumably does not work at Vmax. In
other words, a decrease of the binding a⁄nity of Fet3 for iron
is critical in that it leads to an increase of the overall Km and
thus to a diminished e⁄ciency of the system.
The results obtained for Fet3 H489D deserve further com-
ment: this mutation is particularly critical since His-489 is
also a ligand to type 1 copper. Thus, it is possible that the
mutant protein could be lacking this particular copper atom
and for this reason expression levels are very low (if any), no
oxidase-active band is detected by non-denaturing SDS^
PAGE, and no functional complementation is evident as
both growth and high a⁄nity iron uptake are concerned.
In conclusion, the ¢ndings reported in this paper contribute
to de¢ning the role of the ferroxidase activity of Fet3 in high
a⁄nity iron uptake of S. cerevisiae, as probed by site-directed
mutagenesis. Substitution of each of the four residues pre-
dicted to take part in binding of iron demonstrates that in
all cases Km for high a⁄nity iron uptake is altered. In partic-
ular, a critical role for Glu-185 is evident since replacement of
this residue produces the most severe e¡ects on growth and
Km for iron.
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Table 1
Fe(II) Km values for high a⁄nity iron uptake of S. cerevisiae vfet3
expressing recombinant Fet3
Fet3 Km (WM)
Wild type 0.80 þ 0.15
E185A 4.34 þ 1.23
E185Q 4.25 þ 1.74
Y354F 1.28 þ 0.08
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